A review of systematic reviews of the cost-effectiveness of hormone therapy, chemotherapy, and targeted therapy for breast cancer

A Systematic Review and Methodological Evaluation of Published Cost-Effectiveness Analyses of Aromatase Inhibitors versus Tamoxifen in Early Stage Breast Cancer

(2013) Ava A. John-Baptiste et al.   PLoS One

The global breast cancer burden

(2012) John R Benson et al.   Future Oncology

Methodology in conducting a systematic review of systematic reviews of healthcare interventions

(2011) Valerie Smith et al.   BMC Medical Research Methodology

Delivering affordable cancer care in high-income countries

(2011) Richard Sullivan et al.   LANCET ONCOLOGY

Reviewing the Cost-Effectiveness of Endocrine Early Breast Cancer Therapies: Influence of Differences in Modeling Methods on Outcomes

(2011) Gerardus W.J. Frederix et al.   VALUE IN HEALTH

Cost Effectiveness of Cytotoxic and Targeted Therapy for Metastatic Breast Cancer

(2010) Patricia R. Blank et al.   PHARMACOECONOMICS

AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews

(2009) Beverley J. Shea et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Breast Cancer Screening Policies in Developing Countries: A Cost-effectiveness Analysis for India

(2008) Quirine Lamberts Okonkwo et al.   JNCI-Journal of the National Cancer Institute

Is trastuzumab a cost-effective treatment for breast cancer?

(2008) Tallal Younis et al.   Expert Review of Pharmacoeconomics & Outcomes Research